Document is current
Any future updates will be listed below
-
Authors
Preda, Alberto https://orcid.org/0000-0003-1584-5172
Carbone, Federico https://orcid.org/0000-0003-2957-4078
Tirandi, Amedeo https://orcid.org/0000-0003-1875-0160
Montecucco, Fabrizio https://orcid.org/0000-0003-0823-8729
Liberale, Luca https://orcid.org/0000-0003-1472-7975
-
Funding
Funding for this research was provided by:
Università degli Studi di Genova
- License Information
-
More Information
Article History
Accepted: 31 May 2023
First Online: 26 June 2023
Declarations
:
: Financial or non-financial interests: LL is coinventor on the International Patent WO/2020/226993 filed in April 2020. The patent relates to the use of antibodies which specifically bind IL-1α to reduce various sequelae of ischemia–reperfusion injury to the central nervous system. LL reports speaker fees outside of this work from Daichi-Sankyo.
: N/A.
: N/A.
: All other authors report no conflict of interest.
